BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01030900-completion@plaintrial.com
DTSTAMP:20260928T165021Z
DTSTART;VALUE=DATE:20210806
SUMMARY:Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rit
 uximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hod
 gkin Lymphomas — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01030900
URL:https://plaintrial.com/trial/NCT01030900
END:VEVENT
END:VCALENDAR